Preferred Label : Atazanavir Sulfate;

MeSH definition : An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.;

CISMeF synonym : 73547, CGP; 75136, CGP; 75176, CGP; 75355, CGP; Sulfate, Atazanavir;

MeSH Hyperonym : atazanavir; 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester;

MeSH hyponym : CGP 75176; BMS-232632-05; reyataz; CGP 75355; CGP 75136; CGP 73547; BMS 232632; CGP75176; CGP-75176; CGP-73547; CGP73547; CGP75355; CGP-75355; CGP75136; CGP-75136; BMS 232632 05; BMS23263205; 232632, BMS; BMS-232632; BMS232632;

MeSH Related Number : 229975-97-7; QZU4H47A3S; 198904-31-3 (atazanavir);

Wikipedia link : https://en.wikipedia.org/wiki/Atazanavir sulfate;

Is substance : O;

UNII : 4MT4VIE29P;

Details


Main resources

You can consult :

An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.

https://www.ema.europa.eu/en/medicines/human/EPAR/atazanavir-krka
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Atazanavir Sulfate
Atazanavir Sulfate
atazanavir
hiv infections
HIV-1
hiv protease inhibitors
hiv protease inhibitors
drug therapy, combination
drugs, generic
administration, oral
adult
child
adolescent
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
https://www.ema.europa.eu/medicines/human/EPAR/atazanavir-mylan
2017
false
United Kingdom
English
French
syndication feed
Atazanavir Sulfate
Atazanavir Sulfate
treatment outcome
drugs, generic
Product containing precisely atazanavir (as atazanavir sulfate) 150 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely atazanavir (as atazanavir sulfate) 200 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug)
atazanavir
acquired immunodeficiency syndrome
anti-hiv agents
hiv protease inhibitors
anti-hiv agents
hiv protease inhibitors
hiv infections
drug therapy, combination
adult
HIV-1
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Evotaz
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
hiv protease inhibitors
hiv protease inhibitors
hiv infections
anti-hiv agents
anti-hiv agents
adult
HIV-1
human immunodeficiency virus i infection
administration, oral
drug approval
europe
drug monitoring
product surveillance, postmarketing
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 CYP3A Inhibitors
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
atazanavir and cobicistat
Atazanavir Sulfate
Atazanavir Sulfate
Cobicistat
Cobicistat
Atazanavir/Cobicistat

---
http://www.has-sante.fr/portail/jcms/c_2561597/fr/reyataz
http://www.has-sante.fr/portail/jcms/c_991888/reyataz
2015
false
France
French
human immunodeficiency virus i infection
ritonavir
Atazanavir Sulfate
hiv protease inhibitors
anti-hiv agents
administration, oral
atazanavir
insurance, health, reimbursement
hiv infections
HIV-1
adult
antiretroviral therapy, highly active
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1747985/fr/reyataz-atazanavir-inhibiteur-de-protease
2014
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
administration, oral
treatment outcome
drug therapy, combination
atazanavir
adolescent
child
hiv infections
HIV-1
anti-hiv agents
anti-hiv agents
insurance, health, reimbursement
ritonavir
Atazanavir Sulfate
Atazanavir Sulfate

---
https://www.ema.europa.eu/medicines/human/EPAR/Reyataz
2012
false
United Kingdom
English
French
syndication feed
Atazanavir Sulfate
Atazanavir Sulfate
atazanavir
acquired immunodeficiency syndrome
anti-hiv agents
hiv protease inhibitors
anti-hiv agents
hiv protease inhibitors
hiv infections
drug therapy, combination
adult
HIV-1
drug evaluation
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_882630/reyataz-atazanavir-inhibiteur-de-protease
http://www.has-sante.fr/portail/jcms/c_882629/synthese-d-avis-reyataz-ct-6283
http://www.has-sante.fr/portail/jcms/c_828271/reyataz-ct-6283
2009
false
France
French
Atazanavir Sulfate
Atazanavir Sulfate
hiv infections
anti-hiv agents
atazanavir
hiv protease inhibitors
insurance, health, reimbursement
treatment outcome
HIV-1
adult
drug therapy, combination
hiv protease inhibitors
anti-hiv agents
administration, oral
evaluation of the transparency committee
guidelines for drug use
comparative study

---
http://www.meddispar.fr/medicaments/3640450
2008
false
France
French
Atazanavir Sulfate
capsules
administration, oral
drug prescriptions
legislation, drug
atazanavir
drug information

---
http://www.meddispar.fr/medicaments/3848788
2008
false
France
French
Atazanavir Sulfate
capsules
legislation, drug
administration, oral
drug prescriptions
atazanavir
drug information

---
http://www.meddispar.fr/medicaments/3640438
2008
false
France
French
Atazanavir Sulfate
capsules
administration, oral
drug prescriptions
legislation, drug
atazanavir
drug information

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.